Skip to main content
SpringerLink
Log in

Bulletin de synthèse de veille 2006

Standards, Options et Recommandations. Prise en charge des patients atteints de carcinome de site primitif inconnu

2006 Monitoring Report: Clinical practice guidelines: the management of patients with carcinoma of unknown primary site

  • Recommandations
  • Published:
Oncologie

Résumé

Contexte

La validité des recommandations repose sur leur actualisation au même titre que sur la rigueur du développement initial. Dans ce contexte, les Standards, options et recommandations (SOR) de la Fédération nationale des centres de lutte contre le cancer (FNCLCC) ont mis en place un programme de veille dont l’objectif est de surveiller l’appartition de nouvelles données.

Objectifs

Identifier les informations susceptibles de modifier les recommandations du document « SOR pour la prise en charge des patients atteints de carcinome de site primitif inconnu (2002) », analyser leur impact et informer les utilisateurs sur la validité des recommandations au vu des nouvelles données.

Méthodes

Le processus de veille repose sur trois étapes conduites en collaboration avec des experts: la collecte des données à partir de différentes sources, la sélection et le classement des informations, puis leur traitement.

Résultats

À l’issue du processus de veille, les recommandations relatives au traitement des métastases cervicales d’un carcinome épidermoïde ont été identifiées comme devant être mises à jour. Toutes les autres recommandations du document initial sont valides (jugement argumenté des experts du groupe de travail).

Abstract

Context

The validity of clinical practice guidelines is based on their regular update as well as the quality of the initial guideline development process. The Standards, options and recommendations (SOR) of the French National Federation of Comprehensive Cancer Centres (FNCLCC), therefore, has implemented a literature monitoring process.

Objectives

To identify new data that will likely modify the recommendations set forth in Standards, Options and Recommendations in the Management of Patients with Carcinoma of Unknown Primary Site (2002), evaluate the data’s impact and inform potential users of its validity.

Methods

The monitoring process consists of 3 main steps taken in collaboration with experts: data collection; data selection and classification; and data analysis.

Results

Using this monitoring process, we identified the need for an update of the recommendations for treating the cervical metastases of an epidermoid carcinoma. All other recommendations in the initial document remain valid (explicit and transparent expert determination).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Assersohn L, Norman AR, Cunningham D, et al. (2003) A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary. Eur J Cancer 39: 1121–8

    Article  PubMed  CAS  Google Scholar 

  2. Bernier J, Domenge C, Ozsahin M, et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945–52

    Article  PubMed  CAS  Google Scholar 

  3. Cooper JS, Pajak TF, Forastiere AA, et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350: 1937–44

    Article  PubMed  Google Scholar 

  4. Culine S, Lortholary A, Voigt JJ, et al. (2003) Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study-trial for the French Study Group on Carcinomas of Unknown Primary (GEF-CAPI 01). J Clin Oncol 21: 3479–82

    Article  PubMed  CAS  Google Scholar 

  5. Dowell JE, Garrett AM, Shyr Y, et al. (2001) A randomized Phase II trial in patients with carcinoma of an unknown primary site. Cancer 91: 592–7

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncologue médical, institut Claudius-Regaud, Toulouse, France

    Roland Bugat

  2. FNCLCC, Paris (méthodologiste), France

    François Planchamp

  3. Oncologue médical, centre Eugène-Marquis, Rennes, France

    Thierry Lesimple

  4. Pathologiste, institut Claudius-Regaud, Toulouse, France

    Jean-Jacques Voigt

  5. Oncologue médical, centre Val-d’Aurelle, Montpellier, France

    Stéphane Culine

  6. Oncologue médical, centre Paul-Papin, Angers, France

    Alain Lortholary

  7. Oncologue médical, institut de cancérologie de la Loire, Saint-Étienne, France

    Yacine Merrouche

  8. Oncologue-radiothérapeute, centre Jean-Bernard, Le Mans, France

    Gérard Ganem

  9. Oncologue médical, centre Alexis-Vautrin, Vandœuvre-lès-Nancy, France

    Marie-Christine Kaminsky

  10. Oncologue médical, centre Léon-Bérard, Lyon, France

    Sylvie Négrier

  11. Pneumologue, CHU Croix-Rousse, Lyon, France

    Maurice Pérol

  12. Oncologue médical, institut Gustave-Roussy, Villejuif, France

    Karim Fizazi

  13. Oncologue médical, centre Henri-Becquerel, Rouen, France

    Emmanuel Blot

  14. FNCLCC, 101, rue de Tolbiac, F-75654, Paris Cedex 13, France

    Roland Bugat, François Planchamp, Thierry Lesimple, Jean-Jacques Voigt, Stéphane Culine, Alain Lortholary, Yacine Merrouche, Gérard Ganem, Marie-Christine Kaminsky, Sylvie Négrier, Maurice Pérol, Karim Fizazi & Emmanuel Blot

Authors
  1. Roland Bugat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. François Planchamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thierry Lesimple
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Jacques Voigt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stéphane Culine
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alain Lortholary
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yacine Merrouche
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gérard Ganem
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marie-Christine Kaminsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sylvie Négrier
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Maurice Pérol
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Karim Fizazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Emmanuel Blot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roland Bugat.

Additional information

Tous les droits de reproduction, représentation, ainsi que de traduction sur ce texte appartiennent exclusivement à la FNCLCC, quel que soit le support utilisé. Ainsi, tout projet de reproduction ou de diffusion de ce texte, doit préalablement faire l’objet d’une autorisation expresse de la FNCLCC. © FNCLCC 2007

About this article

Cite this article

Bugat, R., Planchamp, F., Lesimple, T. et al. Bulletin de synthèse de veille 2006. Oncologie 9, 313–316 (2007). https://doi.org/10.1007/s10269-007-0649-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-007-0649-6

Mots clés

Keywords

Search

Navigation